Exelixis to Present at the Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
21 Novembre 2023 - 10:05PM
Business Wire
– Presentation to be webcast on
www.exelixis.com –
Exelixis, Inc. (Nasdaq: EXEL) today announced that company
management will participate in a fireside chat at the Piper Sandler
35th Annual Healthcare Conference on Tuesday, November 28 at 11:00
am ET / 8:00 am PT.
To access the webcast link, log onto www.exelixis.com and
proceed to the Event Calendar page under the Investors & News
heading. Please connect to the company’s website at least 15
minutes prior to the presentation to ensure adequate time for any
software download that may be required to listen to the webcasts. A
replay will also be available at the same location for at least 30
days.
About Exelixis
Exelixis is a globally ambitious oncology company innovating
next-generation medicines and regimens at the forefront of cancer
care. Powered by bi-coastal centers of discovery and development
excellence, we are rapidly evolving our product portfolio to target
an expanding range of tumor types and indications with our
clinically differentiated pipeline of small molecules,
antibody-drug conjugates and other biotherapeutics. This
comprehensive approach harnesses decades of robust investment in
our science and partnerships to advance our investigational
programs and extend the impact of our flagship commercial product,
CABOMETYX® (cabozantinib). Exelixis is driven by a bold scientific
pursuit to create transformational treatments that give more
patients hope for the future. For information about the company and
its mission to help cancer patients recover stronger and live
longer, visit www.exelixis.com, follow @ExelixisInc on X (Twitter),
like Exelixis, Inc. on Facebook and follow Exelixis on
LinkedIn.
Exelixis, the Exelixis logo and CABOMETYX are
registered U.S. trademarks.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231121271903/en/
Investors Contact: Varant Shirvanian Associate Director,
Investor Relations Exelixis, Inc. 650-837-7917
vshirvanian@exelixis.com
Media Contact: Hal Mackins For Exelixis, Inc.
415-994-0040 hal@torchcommunications.com
Exelixis (NASDAQ:EXEL)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Exelixis (NASDAQ:EXEL)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024